Oncternal Therapeutics Inc (ONCT)

$8.64 0.08 (0.94%)

15:37 EDT ONCT Stock Quote Delayed 30 Minutes

ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023

ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles

Volume:

Previous Close -

Market Cap 506.97M

PE Ratio -43.18

EPS -0.2

Volume (Avg. Vol.) 1,695

Day's Range $8.64 - $8.64

52-Week Range $0.28 - $10.61

Dividend & Yield N/A (N/A)

ONCT Stock Predictions, Articles, and Oncternal Therapeutics Inc News

From InvestorPlace
From the Web

Why Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?

By William White, InvestorPlace Writer Apr 4, 2023

Oncternal Therapeutics (ONCT) stock is falling hard on Tuesday after the company decided to end two clinical trials to switch focus.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 4, 2023

It's time to dive into the biggest pre-market stock movers for Tuesday morning with all the latest news traders need to know about!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 12, 2022

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 31, 2022

Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 28, 2021

Good morning! Let's get ready for trading to start off strong this week with a look at the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer May 20, 2021

Welcome back again, investors, and let's get ready for a busy day of trading with a look at the biggest pre-market stock movers for Thursday!

Oncternal Therapeutics announces a reverse stock split (NASDAQ:ONCT)

From Seeking Alpha Jan 4, 2024

Oncternal Therapeutics announced a reverse stock split to comply with Nasdaq's minimum bid price requirement.

Oncternal stock slips after lymphoma drug data (NASDAQ:ONCT)

From Seeking Alpha Dec 26, 2023

Oncternal Therapeutics (ONCT) shares fell in reaction to initial results from its Phase 1/2 study for CAR T cell therapy in B-cell lymphoma. Read more here.

Oncternal stock jumps 9% on FDA fast track designation (NASDAQ:ONCT)

From Seeking Alpha Oct 26, 2023

Oncternal Therapeutics (ONCT) stock climbs 9% after FDA grants fast track status to its prostate cancer drug candidate ONCT-534. Read more here.

Analysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT) and Cutera (CUTR)

From TipRanks Nov 5, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oncternal Therapeutics (

Oncternal Therapeutics (ONCT) Receives a Buy from H.C. Wainwright

From TipRanks Nov 4, 2022

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Oncternal Therapeutics (ONCT – Research Report), with a price target...

H.C. Wainwright Keeps Their Buy Rating on Oncternal Therapeutics (ONCT)

From TipRanks Sep 2, 2022

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oncternal Therapeutics (ONCT – Research Report) today and set a price target of $7.00. The co...

ADVERTISEMENT